and Control of Cardiovascular Diseases: What Works?



Fig. 1
Prevention and control of CVDs—what works?





Acknowledgements

We would like to give thanks to Svetlana Mosteoru, MD, for the outstanding help in the process of writing this chapter.


References



1.

Banegas JR, López-García E, Dallongeville J, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011;32(17):2143–52.PubMedCentralCrossRefPubMed


2.

Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009;16(2):121–37.CrossRefPubMed


3.

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al. European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2012;33(13):1635–701.


4.

Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362:847–52.CrossRefPubMed


5.

Barone-Adesi F, et al. Public smoking ban: Europe on the move. Eur Heart J. 2006;27(20):2385–6.CrossRef


6.

Raupach T, Schäfer K, Konstantinides S, Andreas S. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J. 2006;27(4):386–92.CrossRefPubMed


7.

Al Mamun A, Peeters A, Barendregt J, et al., NEDCOM; The Netherlands Epidermiology and Demography Compression of Morbidity Research Group. Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study. Eur Heart J. 2004;25(5):409–15.


8.

Casanovas JA, la Petra A, Puzo J, et al. Tobacco, physical exercise and lipid profile. Eur Heart J. 1992;13(4):440–5.


9.

Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2004;1:CD003041.PubMed


10.

Mottillo S, Filion KB, Bélisle P, et al. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30(6):718–30.CrossRefPubMed


11.

Mensink RP, Zock PL, Kester ADM, et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146–55.PubMed


12.

Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2011;32(14):1769–818.


13.

O’Donnell MJ, Mente A, Smythand A, et al. Salt intake and cardiovascular disease: why are the data inconsistent? Eur Heart J. 2013;34(14):1034–40.CrossRefPubMed


14.

Zoghbi WA, Duncan T, Antman E, Barbosa M, Champagne B, Chen D, et al. Sustainable Development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce. Glob Heart. 2014;9(3):273–4. doi:10.​1016/​j.​gheart.​2014.​09.​003. Epub 2014 Sep 22.CrossRefPubMed
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. of Primordial and Primary Prevention for Cardiovascular Diseases: A Global Perspective
  2. Disease in Women: An Update
  3. Fibrillation and Stroke Prevention
  4. and Control of Cardiovascular Diseases: Integrated and Complimentary Strategies

Stay updated, free articles. Join our Telegram channel
Tags:
Jul 13, 2016 | Posted by in CARDIOLOGY | Comments Off on and Control of Cardiovascular Diseases: What Works?

Full access? Get Clinical Tree
Get Clinical Tree app for offline access